Optimum Client’s Nominated for Scrip Awards 2019

We are thrilled to see our excellent clients recognised at this years Scrip Awards 2019. Great to see Calliditas and our friends at Galapagos nominated for Biotech Company of the Year Award, and Artios Pharma a finalist for the Financing Deal Of The Year Award! Roll on Wednesday 4th December, where we can celebrate! Nominees listed below.

WuXi App Tec’s Biotech Company of the Year Award

Allogene Therapeutics

Achilles Therapeutics

Galapagos

Alnylam Pharmaceuticals

Oxford Biomedica

HOOKIPA Pharma

Calliditas Therapeutics

Financing Deal of the Year

Allogene Therapeutics’ $372.6m IPO

Artios’s $84m series B financing

Cambridge Innovation Capital £150m funding round

Galapagos’s $345m secondary follow-on financing

iTeos Therapeutics’ $75m series B financing

Sensyne Health’s £60m IPO

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH